Skip to main content
. 2012 Jun;3(2):74–78. doi: 10.1016/j.phrp.2012.04.001

Table 2.

Differentially expressed cellular proteins, as identified by LC-MS/MS, between fluconazole-susceptible and -resistant C glabrata strains

Spot Protein Molecular mass (kDa) pI Protein coverage (%) Fold change (R/S)*

288 Unnamed protein 61.726 5.59 10 1.90
64 Fructose bisphosphate aldolase 39.322 5.49 4 1.90
82 Phosphoglycerate kinase 44.590 6.37 16 1.71
286 GroEL-like type I chaperonin 60.351 5.14 5 –2.50
287, 290, 217, 284, 248 Heat shock protein70 66.355 5.32 5 –2.31
272, 270, 273 Hexokinase 53.772 5.23 32 –2.30
187 Putative oxidoreductase 33.032 5.01 4 –2.15
282, 250 Putative pyruvate decarboxylase 61.531 5.43 6 –2.09
281 Pyruvate kinase 55.060 6.08 6 –2.03
41 DNA-dependent RNA polymerase II 38.917 7.7 7 –1.95
141 Mitochondrial aconitase hydratase 84.169 5.96 1 –1.83
138 CoA-transferase 57.167 8.46 5 –1.75
176 IPP1P inorganic pyrophosphatase 14.532 4.84 83 –1.66

*Expression ratio of fluconazole-resistant (R) over fluconazole-susceptible (S) strains. The minus sign (-) indicates decreased protein expression of fluconazole-resistant strains in comparison with fluconazole-susceptible strains.

LC-MS/MS: liquid chromatography-tandem mass spectrometry.